https://scholars.lib.ntu.edu.tw/handle/123456789/588822
標題: | Revaccination with 7-valent pneumococcal conjugate vaccine elicits better serologic response than 23-valent pneumococcal polysaccharide vaccine in HIV-infected adult patients who have undergone primary vaccination with 23-valent pneumococcal polysaccharide vaccine in the era of combination antiretroviral therapy | 作者: | Lu C.-L. SUI-YUAN CHANG YU-CHUNG CHUANG Liu W.-C. Su C.-T. Su Y.-C. Chang S.-F. CHIEN-CHING HUNG |
公開日期: | 2014 | 卷: | 32 | 期: | 9 | 起(迄)頁: | 1031-1035 | 來源出版物: | Vaccine | 摘要: | HIV-infected adults who had received 23-valent pneumococcal polysaccharide vaccine (PPV23) five years or more earlier consecutively underwent revaccination with one dose of PPV23 (127 subjects) from December 2005 through October 2007, or upon change in standard of care, non-randomly one (50) or two doses (44) of 7-valent pneumococcal conjugate vaccine (PCV7) from October 2008 through June 2010. Serologic response was defined as ?2-fold increase in the IgG level plus a level ?1000. ng/ml 48 weeks following revaccination. At week 48, the response rate was significantly higher in the 2-dose PCV7 group compared with that in the 1-dose PCV7 or PPV23 group (63.6% vs 32.0% vs 8.7%, respectively; P<. 0.05). Revaccination with one dose of PCV7 (AOR, 4.57), two doses of PCV7 (AOR, 22.66), and CD4 >350 cells/μl (AOR, 3.24) and undetectable viral load (AOR, 3.87) at revaccination were statistically significantly associated with a better serologic response at week 48. Despite the limitation that study arms were neither randomized nor contemporaneous, we conclude that revaccination with PCV7 appears to elicit a better serologic response than PPV23 in the HIV-infected adults who have received PPV23 five years or more earlier (clinical trial registration number: NCT00885625). ? 2014 Elsevier Ltd. |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-84895063141&doi=10.1016%2fj.vaccine.2014.01.009&partnerID=40&md5=cd80e7658599d9f032062ba747e518d9 https://scholars.lib.ntu.edu.tw/handle/123456789/588822 |
ISSN: | 0264-410X | DOI: | 10.1016/j.vaccine.2014.01.009 | SDG/關鍵字: | Hyporesponsiveness; Immunization; Immunogenicity; Pneumococcal vaccination; Streptococcus pneumoniae; Adult; Antibodies, Bacterial; CD4 Lymphocyte Count; Female; Follow-Up Studies; HIV Infections; Humans; Immunization, Secondary; Immunoglobulin G; Male; Middle Aged; Pneumococcal Vaccines; Superior Sagittal Sinus; Viral Load |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。